As those in Washington continue to make their arguments for or against the proposed health care reform bill, those in the healthcare industry are spending millions to have their views heard. One large sector of the health care system is the pharmaceutical industry. National Public Radio (NPR) recently reported that the Pharmaceutical Research and Manufacturers of America, or PhRMA, paid approximately $40 million to lobbyists just this spring. In doing so, PhRMA sought to make early changes to the bill which would be beneficial to both health care consumers and the pharmaceutical industry.

Read the full post on Pharmaceutical Companies and the New Health Care Bill.